CSTL
NASDAQStockCastle Biosciences, Inc.
$25.37+0.05 (+0.18%)
52-Week Range
$14.65
$43.04
Key Stats
Market Cap
754.1M
P/E Ratio
—
Dividend Yield
—
Beta
1.13
Volume
150.4K
Avg Volume
497.0K
Performance
1M
-20.63%
3M
-34.88%
6M
+17.11%
YTD
-34.30%
1Y
+31.26%
3Y
+11.79%
5Y
-61.50%
Price Chart
ETF Exposure
CSTL is held by 116 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| XUU.TO | iShares Core S&P U.S. Total Market Index ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| XEQT.TO | iShares Core Equity ETF Portfolio | 0.00% |
PreviousPage 3 of 3
About CSTL ETF Exposure
Castle Biosciences, Inc. (CSTL) is held by 116 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 754.1M, CSTL is a widely held institutional stock. The stock currently trades at $25.37. Investors can gain exposure to CSTL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CSTL, sorted by portfolio weight.